Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Epilepsy × Sirolimus × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2 Neoplasms 2 Sturge-Weber Syndrome 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Epilepsy 1 Cognitive Dysfunction 1 Carcinoma, Hepatocellular 1

Interventions

Vigabatrin 1 Sirolimus 1 Fluid Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Recruiting

Epilepsy, Neoplasms, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡